This study investigates how 24-hour urinary biomarkers can predict whether children suffering from orthostatic intolerance (OI)—conditions like fainting or rapid heart rate upon standing—will experience a relapse after a year of standard physical treatment. The researchers found that elevated levels of urinary adrenaline and norepinephrine, along with specific electrolyte imbalances, serve as significant red flags for recurrence.
TL;DR
Researchers have identified that 24-hour urinary catecholamines (adrenaline and norepinephrine) and electrolytes are potent predictors for the recurrence of orthostatic intolerance in children. By analyzing these biomarkers, clinicians may be able to identify high-risk patients who require more intensive management following initial physical therapy.
What Problem Does This Paper Address?
Orthostatic intolerance (OI) is a common but disruptive condition in the pediatric population, encompassing disorders like Vasovagal Syncope (VVS) and Postural Tachycardia Syndrome (POTS). While many children improve with "physical treatment"—a regimen of increased salt/water intake, exercise, and trigger avoidance—a significant number suffer from recurrences.
The challenge lies in the "black box" of the autonomic nervous system. Current clinical tools often fail to predict who will relapse. Previous studies on blood-based biomarkers have yielded inconsistent results because blood levels fluctuate rapidly. This paper addresses the need for more stable, long-term biomarkers by turning to 24-hour urine collection to assess the body's overall neurohumoral state.
Methods
The authors conducted a retrospective study of 320 children (ages 5–18) diagnosed with VVS, POTS, or a combination of both at Qilu Hospital of Shandong University.
- Treatment: All patients underwent one year of standardized physical therapy.
- Biomarker Testing: Following a Head-Up Tilt Test (HUTT), researchers collected 24-hour urine samples and morning blood samples.
- Analytical Techniques:
- HPLC-MS: High-performance liquid chromatography–mass spectrometry was used to quantify urinary catecholamines (adrenaline, norepinephrine, and dopamine).
- Standard Assays: Used for plasma renin, angiotensin II, aldosterone, and electrolytes (sodium, potassium, chlorine, etc.).
- Statistical Validation: The team used multivariate logistic regression to find independent risk factors and Receiver Operating Characteristic (ROC) curves to calculate the predictive accuracy (Area Under the Curve, or AUC) of these markers.
Datasets
The study utilized a clinical dataset of 320 pediatric patients, categorized into three cohorts:
- VVS Cohort: 204 patients (the largest group).
- POTS Cohort: 43 patients.
- VVS + POTS Cohort: 73 patients.
The data included baseline clinical manifestations (seizure frequency, triggers) and a comprehensive panel of biochemical indicators from both blood and urine.
Key Insights and Ideas
- Urine as a "Buffer" for Data: Unlike plasma catecholamines, which spike and dip in seconds, 24-hour urinary excretion provides a cumulative "integrated" view of the sympathetic nervous system's activity over a full day-night cycle.
- Mechanistic Divergence: The predictors for recurrence differed by diagnosis.
- In VVS, recurrence was primarily driven by higher adrenaline (AD) and norepinephrine (NE) levels, suggesting a hyper-reactive sympathetic nervous system.
- In POTS, recurrence was linked to higher urinary sodium and chlorine, potentially indicating a baseline state of salt-wasting or a higher physiological requirement for volume expansion that wasn't met by standard therapy.
- The Power of Combination: The study suggests that an integrated evaluation system—merging both AD and NE data—offers better predictive power than looking at a single molecule in isolation.
Key Results
- VVS Recurrence: Children who relapsed had significantly higher urinary adrenaline (6.75 vs. 4.10 μg/24h) and norepinephrine. The AUC for urinary adrenaline was 0.617, with a cut-off value of 5.62 μg/24h.
- POTS Recurrence: Higher urinary sodium (199.38 vs. 147.33 mmol/L) and chlorine were the standout predictors.
- VVS + POTS Recurrence: This group showed the strongest predictive results. Urinary adrenaline reached an AUC of 0.738 (cut-off 5.53 μg/24h). Additionally, lower levels of urinary potassium and phosphorus were associated with recurrence in this combined cohort.
- Independent Risk Factors: Multivariate analysis confirmed that urinary adrenaline is an independent prognostic factor for children with combined VVS and POTS.
Limitations and Future Work
The authors acknowledge several limitations:
- Single-Center Study: The data comes from one hospital in China, which may limit the generalizability of the specific "cut-off" values to other populations with different diets or genetics.
- Retrospective Design: This can introduce recall bias regarding the frequency of fainting episodes.
- Sample Size: The POTS-only cohort was relatively small (n=43), which may have obscured some statistical significances.
Future Work: The researchers call for large-scale, multi-center prospective studies to validate these biomarkers. They also suggest investigating the role of Vitamin B12 and other metabolic enzymes (like PNMT) that regulate catecholamine levels to better understand the underlying pathophysiology of OI recurrence.
Summary updated